Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective

Redox Biology

Volumn 2, Issue 1, 2014, Pages 921-928

  Koutakis, Panagiotis ^a   Weiss, Dustin J ^a   Miserlis, Dimitrios ^a   Shostrom, Valerie K ^b   Papoutsi, Evlampia ^a   Ha, Duy M ^a   Carpenter, Lauren A ^a   McComb, Rodney D ^a   Casale, George P ^a   Pipinos, Iraklis I ^a,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Carbonyl groups; Fontaine Stage; Oxidative damage

Indexed keywords

CARBONYL DERIVATIVE; MYOSIN I; MYOSIN II;

ADULT; ARTICLE; CELL SIZE; CELL TYPE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MUSCLE CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUANTITATIVE ANALYSIS; AGED; METABOLISM; MIDDLE AGED; PATHOLOGY; SKELETAL MUSCLE;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OXIDATIVE STRESS; PERIPHERAL ARTERIAL DISEASE;

EID: 84905855845     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.07.002     Document Type: Article

References (43)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G. Inter-society consensus for the management of peripheral arterial disease (TASC II). Journal of Vascular Surgery 2007, 45(Suppl. S):S5-67. On behalf of the TASC II Working Group. 10.1016/j.redox.2014.07.002.
2. Cluff K., Miserlis D., Naganathan G.K., Pipinos I.I., Koutakis P., Samal A., McComb R.D., Subbiah J., Casale G.P. Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: Objective grading of muscle degeneration. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2013, 305:R291-R299. http://www.ncbi.nlm.nih.gov/pubmed/23720135, 10.1016/j.redox.2014.07.002.
3. Hedberg B., Angquist K.A., Henriksson-Larsen K., Sjöström M. Fibre loss and distribution in skeletal muscle from patients with severe peripheral arterial insufficiency. European Journal of Vascular Surgery 1989, 3:315-322. http://www.ncbi.nlm.nih.gov/pubmed/2767254, 10.1016/j.redox.2014.07.002.
4. Pipinos I.I., Judge A.R., Selsby J.T., Zhu Z., Swanson S.A., Nella A.A., Dodd S.L. The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. Vascular and Endovascular Surgery 2008, 42:101-112. http://www.ncbi.nlm.nih.gov/pubmed/18390972, 10.1016/j.redox.2014.07.002.
5. Pipinos I.I., Judge A.R., Zhu Z., Selsby J.T., Swanson S.A., Johanning J.M., Baxter B.T., Lynch T.G., Dodd S.L. Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radical Biology & Medicine 2006, 41:262-269. http://www.ncbi.nlm.nih.gov/pubmed/16814106, 10.1016/j.redox.2014.07.002.
6. Pipinos I.I., Swanson S.A., Zhu Z., Nella A.A., Weiss D.J., Gutti T.L., McComb R.D., Baxter B.T., Lynch T.G., Casale G.P. Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2008, 295:R290-R296. http://www.ncbi.nlm.nih.gov/pubmed/18480238, 10.1016/j.redox.2014.07.002.
7. Pipinos I.I., Judge A.R., Selsby J.T., Zhu Z., Swanson S.A., Nella A.A., Dodd S.L. The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vascular and Endovascular Surgery 2007, 41:481-489. http://www.ncbi.nlm.nih.gov/pubmed/18166628, 10.1016/j.redox.2014.07.002.
8. Pipinos I.I., Shepard A.D., Anagnostopoulos P.V., Katsamouris A., Boska M.D. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. Journal of Vascular Surgery 2000, 31:944-952. http://www.ncbi.nlm.nih.gov/pubmed/10805885, 10.1016/j.redox.2014.07.002.
9. Regensteiner J.G., Wolfel E.E., Brass E.P., Carry M.R., Ringel S.P., Hargarten M.E., Stamm E.R., Hiatt W.R. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 1993, 87:413-421. http://www.ncbi.nlm.nih.gov/pubmed/8425290, 10.1016/j.redox.2014.07.002.
10. Weiss D.J., Casale G.P., Koutakis P., Nella A.A., Swanson S.A., Zhu Z., Miserlis D., Johanning J.M., Pipinos I.I. Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease. Journal of Translational Medicine 2013, 11:230. http://www.ncbi.nlm.nih.gov/pubmed/24067235, 10.1016/j.redox.2014.07.002.
11. Rubinstein N.A., Kelly A.M. Development of muscle fiber specialization. Myology 2004, 87-101. McGraw-Hill, New York, NY, USA. A.G. Engel, C. Franzini-Armstrong (Eds.).
12. Hirao T., Takahashi M. Carbonylation of cornified envelopes in the stratum corneum. FEBS Letters 2005, 579:6870-6874. http://www.ncbi.nlm.nih.gov/pubmed/16336969, 10.1016/j.redox.2014.07.002.
13. Huang D., Casale G.P., Tian J., Lele S.M., Pisarev V.M., Simpson M.A., Hemstreet G.P. UDP-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer. International Journal of Cancer 2010, 126:315-327. 10.1016/j.redox.2014.07.002.
14. Huang D., Casale G.P., Tian J., Wehbi N.K., Abrahams N.A., Kaleem Z., Smith L.M., Johansson S.L., Elkahwaji J.E., Hemstreet G.P. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. Cancer Epidemiology, Biomarkers & Prevention 2007, 16:1371-1381. http://www.ncbi.nlm.nih.gov/pubmed/17623804, 10.1016/j.redox.2014.07.002.
15. Hedberg B., Angquist K.A., Sjöström M. Peripheral arterial insufficiency and the fine structure of the gastrocnemius muscle. International Angiology: A Journal of the International Union of Angiology 1988, 7:50-59. http://www.ncbi.nlm.nih.gov/pubmed/3385269.
16. Sanger J.W., Wang J., Fan Y., White J., Sanger J.M. Assembly and dynamics of myofibrils. Journal of Biomedicine & Biotechnology 2010, 2010:858606. http://www.ncbi.nlm.nih.gov/pubmed/20625425, 10.1016/j.redox.2014.07.002.
17. Sanger J.W., Sanger J.M., Franzini-Armstrong C. Assembly of the skeletal muscle cell. Myology 2004, 45-65. McGraw-Hill, New York, NY, USA. A.G. Engel, C. Franzini-Armstrong (Eds.).
18. Ciciliot S., Rossi A.C., Dyar K.A., Blaauw B., Schiaffino S. Muscle type and fiber type specificity in muscle wasting. International Journal of Biochemistry & Cell Biology 2013, 45:2191-2199. http://www.ncbi.nlm.nih.gov/pubmed/23702032, 10.1016/j.redox.2014.07.002.
19. Johns N., Stephens N.A., Fearon K.C.H. Muscle wasting in cancer. International Journal of Biochemistry & Cell Biology 2013, 45:2215-2229. 10.1016/j.redox.2014.07.002.
20. 2 production promotes endothelial NF-kappaB activation in aged rat arteries. American Journal of Physiology. Heart and Circulatory Physiology 2007, 293:H37-H47. http://www.ncbi.nlm.nih.gov/pubmed/17416599, 10.1016/j.redox.2014.07.002.
21. Ungvari Z., Labinskyy N., Gupte S., Chander P.N., Edwards J.G., Csiszar A. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. American Journal of Physiology. Heart and Circulatory Physiology 2008, 294:H2121-H2128. http://www.ncbi.nlm.nih.gov/pubmed/18326800, 10.1016/j.redox.2014.07.002.
22. Donato A.J., Uberoi A., Wray D.W., Nishiyama S., Lawrenson L., Richardson R.S. Differential effects of aging on limb blood flow in humans. American Journal of Physiology. Heart and Circulatory Physiology 2006, 290:H272-H278. http://www.ncbi.nlm.nih.gov/pubmed/16183733, 10.1016/j.redox.2014.07.002.
23. Behnke B.J., Delp M.D., Dougherty P.J., Musch T.I., Poole D.C. Effects of aging on microvascular oxygen pressures in rat skeletal muscle. Respiratory Physiology & Neurobiology 2005, 146:259-268. http://www.ncbi.nlm.nih.gov/pubmed/15766914, 10.1016/j.redox.2014.07.002.
24. Russell J.A., Kindig C.A., Behnke B.J., Poole D.C., Musch T.I. Effects of aging on capillary geometry and hemodynamics in rat spinotrapezius muscle. American Journal of Physiology. Heart and Circulatory Physiology 2003, 285:H251-H258. http://www.ncbi.nlm.nih.gov/pubmed/12649079, 10.1016/j.redox.2014.07.002.
25. Anderson E.J., Neufer P.D. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. American Journal of Physiology. Cell Physiology 2006, 290:C844-C851. http://www.ncbi.nlm.nih.gov/pubmed/16251473, 10.1016/j.redox.2014.07.002.
26. Stefanyk L.E., Coverdale N., Roy B.D., Peters S.J., LeBlanc P.J. Skeletal muscle type comparison of subsarcolemmal mitochondrial membrane phospholipid fatty acid composition in rat. Journal of Membrane Biology 2010, 234:207-215. http://www.ncbi.nlm.nih.gov/pubmed/20336283, 10.1016/j.redox.2014.07.002.
27. Wang Y., Pessin J.E. Mechanisms for fiber-type specificity of skeletal muscle atrophy. Current Opinion in Clinical Nutrition and Metabolic Care 2013, 16:243-250. http://www.ncbi.nlm.nih.gov/pubmed/23493017, 10.1016/j.redox.2014.07.002.
28. Schiaffino S., Dyar K.A., Ciciliot S., Blaauw B., Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS Journal 2013, 280:4294-4314. http://www.ncbi.nlm.nih.gov/pubmed/23517348, 10.1016/j.redox.2014.07.002.
29. Huang Z., Chen X., Chen D. Myostatin: A novel insight into its role in metabolism, signal pathways, and expression regulation. Cellular Signalling 2011, 23:1441-1446. http://www.ncbi.nlm.nih.gov/pubmed/21609762, 10.1016/j.redox.2014.07.002.
30. Cai D., Frantz J.D., Tawa N.E., Melendez P.A., Oh B.C., Lidov H.G., Hasselgren P.O., Frontera W.R., Lee J., Glass D.J., Shoelson S.E. IKKβ/NF-κBactivation causes severe muscle wasting in mice. Cell 2004, 119:285-298. http://www.ncbi.nlm.nih.gov/pubmed/15479644, 10.1016/j.redox.2014.07.002.
31. Mendias C.L., Gumucio J.P., Davis M.E., Bromley C.W., Davis C.S., Brooks S.V. Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis. Muscle & Nerve 2012, 45:55-59. http://www.ncbi.nlm.nih.gov/pubmed/22190307, 10.1016/j.redox.2014.07.002.
32. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412. http://www.ncbi.nlm.nih.gov/pubmed/15109499, 10.1016/j.redox.2014.07.002.
33. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., Goldberg A.L., Schiaffino S., Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metabolism 2007, 6:458-471. http://www.ncbi.nlm.nih.gov/pubmed/18054315, 10.1016/j.redox.2014.07.002.
34. Selsby J.T., Morine K.J., Pendrak K., Barton E.R., Sweeney H.L. Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PloS One 2012, 7:e30063. http://www.ncbi.nlm.nih.gov/pubmed/22253880, 10.1016/j.redox.2014.07.002.
35. Sandri M., Lin J., Handschin C., Yang W., Arany Z.P., Lecker S.H., Goldberg A.L., Spiegelman B.M. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:16260-16265. http://www.ncbi.nlm.nih.gov/pubmed/17053067, 10.1016/j.redox.2014.07.002.
36. Takikita S., Schreiner C., Baum R., Xie T., Ralston E., Plotz P.H., Raben N. Fiber type conversion by PGC-1alpha activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle. PloS One 2010, 5:e15239. http://www.ncbi.nlm.nih.gov/pubmed/21179212, 10.1016/j.redox.2014.07.002.
37. Wing S.S., Lecker S.H., Jagoe R.T. Proteolysis in illness-associated skeletal muscle atrophy: From pathways to networks. Critical Reviews in Clinical Laboratory Sciences 2011, 48:49-70. http://www.ncbi.nlm.nih.gov/pubmed/21699435, 10.1016/j.redox.2014.07.002.
38. Brass E.P., Hiatt W.R., Gardner A.W., Hoppel C.L. Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. American Journal of Physiology. Heart and Circulatory Physiology 2001, 280:H603-H609. http://www.ncbi.nlm.nih.gov/pubmed/11158957.
39. Makris K.I., Nella A.A., Zhu Z., Swanson S.A., Casale G.P., Gutti T.L., Judge A.R., Pipinos I.I. Mitochondriopathy of peripheral arterial disease. Vascular 2007, 15:336-343. http://www.ncbi.nlm.nih.gov/pubmed/18053417, 10.1016/j.redox.2014.07.002.
40. Rubinstein N.A., Kelly A.M. Development of muscle fiber specialization in the rat hindlimb. Journal of Cell Biology 1981, 90:128-144. http://www.ncbi.nlm.nih.gov/pubmed/7251670, 10.1016/j.redox.2014.07.002.
41. Koutakis P., Johanning J.M., Haynatzki G.R., Myers S.A., Stergiou N., Longo G.M., Pipinos I.I. Abnormal joint powers before and after the onset of claudication symptoms. Journal of Vascular Surgery 2010, 52:340-347. http://www.ncbi.nlm.nih.gov/pubmed/20670775, 10.1016/j.redox.2014.07.002.
42. Koutakis P., Pipinos I.I., Myers S.A., Stergiou N., Lynch T.G., Johanning J.M. Joint torques and powers are reduced during ambulation for both limbs in patients with unilateral claudication. Journal of Vascular Surgery 2010, 51:80-88. http://www.ncbi.nlm.nih.gov/pubmed/19837536, 10.1016/j.redox.2014.07.002.
43. Myers S.A., Johanning J.M., Stergiou N., Celis R.I., Robinson L., Pipinos I.I. Gait variability is altered in patients with peripheral arterial disease. Journal of Vascular Surgery 2009, 49:924-931. http://www.ncbi.nlm.nih.gov/pubmed/19217749, 10.1016/j.redox.2014.07.002.